News | September 08, 2025
Strides partners with Kenox to expand nasal spray portfolio for US market
Kenox to provide formulation and development expertise in orally inhaled and nasal drug products
Kenox to provide formulation and development expertise in orally inhaled and nasal drug products
Under the terms of this agreement, Synthon will be responsible for obtaining final regulatory approval for its Ozanimod Capsules product
This is Lupin's first product using proprietary Nanomi's technology and has a 180-day CGT exclusivity
Milrinone is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure
Fortis will assume complete operational and financial control, allowing it to consolidate the hospital's performance within its network
Enters the high growth vitamins, minerals and supplements segment for adults, paediatrics, and animal health
At the end of the current inspection, a 'Form 483' was issued with 5 observations which are procedural in nature and no data integrity issues were reported
Saroglitazar was generally well tolerated, with overall adverse events generally balanced between Saroglitazar-treated and placebo-treated patients
The new lineup includes CereTom Elite, OmniTom Elite, OmniTom Elite PCD, and BodyTom 32/64
Earlier in July 2025, Dazublys has received the marketing authorisation in the European Union from the European Commission
Subscribe To Our Newsletter & Stay Updated
